Tiziana Announces Positive Data on Intranasal Anti-CD3 Monoclonal Antibody in Intracerebral Hemorrhage Tiziana planning to advance foralumab, the only fully human anti-CD3 monoclonal antibody, into human testing for hemorrhagic strokeData shows behavioral outcomes improvement at one month in model of...

Stroke Management Market to hit USD 59 Billion by 2032, says Global Market Insights Inc. Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The stroke management market value is projected to reach USD 59 billion by 2032, according to a new research report by Global Market...

Stroke management Market revenue to cross USD 48.5 Bn by 2027: Global Market Insights Inc. Selbyville, Delaware, Sept. 15, 2021 (GLOBE NEWSWIRE) -- According to latest report “Stroke management Market by Type (Ischemic, Hemorrhagic, Transient Ischemic Attack {TIA}), Product (Diagnostic...

Stroke Management Market revenue to hit $44.5 billion by 2025: Global Market Insights, Inc. Selbyville, Delaware, July 01, 2019 (GLOBE NEWSWIRE) -- North America stroke management market accounted for more than 33.5% revenue share in 2018 and is projected to witness momentous growth over...